Correlation Between MetaVia and NLS Pharmaceutics

Can any of the company-specific risk be diversified away by investing in both MetaVia and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MetaVia and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MetaVia and NLS Pharmaceutics AG, you can compare the effects of market volatilities on MetaVia and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MetaVia with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MetaVia and NLS Pharmaceutics.

Diversification Opportunities for MetaVia and NLS Pharmaceutics

-0.39

Correlation Coefficient

MetaVia  NLS Pharmaceutics

Very good diversification

The 3 months correlation between MetaVia and NLS is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding MetaVia and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and MetaVia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MetaVia are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of MetaVia i.e., MetaVia and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between MetaVia and NLS Pharmaceutics

Given the investment horizon of 90 days MetaVia is expected to generate 2.03 times more return on investment than NLS Pharmaceutics. However, MetaVia is 2.03 times more volatile than NLS Pharmaceutics AG. It trades about 0.1 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.15 per unit of risk. If you would invest  60.00  in MetaVia on August 3, 2025 and sell it today you would earn a total of  39.00  from holding MetaVia or generate 65.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

MetaVia  vs.  NLS Pharmaceutics AG

MetaVia

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in MetaVia are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, MetaVia sustained solid returns over the last few months and may actually be approaching a breakup point.

NLS Pharmaceutics

Risk-Adjusted Performance

Weakest

Over the last 90 days NLS Pharmaceutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with MetaVia and NLS Pharmaceutics

The main advantage of trading using opposite MetaVia and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MetaVia position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.

The idea behind MetaVia and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.